At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Omnipod Horizon™ Automated Glucose Control Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Safety and Effectiveness of the Omnipod Horizon™ CGM-informed Bolus Calculator in Patients With Type 1 Diabetes
In Brief
A clinical study evaluating Omnipod Horizon™ Automated Glucose Control System for Type 1 Diabetes. Completed, enrolled 25 participants across 4 sites.
Detailed Summary
Subjects will use the Omnipod Horizon™ System in Manual Mode in an outpatient setting for 14-days. Subjects will be trained to use the Manual Mode feature of the Omnipod Horizon™ System including how to use the bolus calculator using manual entry of blood glucose values or by using the CGM-informed bolus calculator.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMar 2020
Enrollment StartJun 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedMar 24, 2020
Enrollment StartJun 9, 2020
Primary CompletionSep 29, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.3 years ago
Interventions
Omnipod Horizon™ Automated Glucose Control Systemdevice
Omnipod Horizon™ Automated Glucose Control System use in Manual Mode